期刊文献+

以姜黄为例解析《欧盟传统草药专论》 被引量:4

下载PDF
导出
摘要 目的:以姜黄为例解析《欧盟传统草药专论》,为中药建立欧盟传统草药专论(CHM)提供参考。方法:以姜黄为实例对欧盟传统草药专论进行研究,深入解析其建立程序及相关重要文件,从实证研究角度明确欧盟草药专论的建立流程与评价关键。结果:《欧盟传统草药专论》在中药有效性与安全性评价以及中药产品欧盟注册中发挥着极其重要的作用。结论:建议由我国政府相关行业主管部门牵头相关单位协助,结合国内研究基础以及厂家申报注册所涉及具体中药品种情况,与欧洲药品局(EMA)展开类似交流合作,及早建立相当数量的中药CHM,助力中药产品欧盟注册,推动中药标准化和国际化进程。
机构地区 成都中医药大学
出处 《中药材》 CAS CSCD 北大核心 2016年第5期1002-1006,共5页 Journal of Chinese Medicinal Materials
基金 国家科技部"十二五"重大新药创制专项(2012ZX09101231)
  • 相关文献

参考文献11

  • 1瞿礼萍,王文珺,周祯祥,张廷模,邹文俊.基于“欧盟草药专论”解析中药欧盟注册关键问题[J].中草药,2014,45(24):3509-3514. 被引量:12
  • 2The European Parliament and the Council of the European Union. Directive 2004/24/EC of the European Parliament and the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/ EC on the Community code relating to medicinal products for human use [J]. Official Journal of the European Union, 2004,47(L-136) :85.
  • 3Peschel W. The use of community herbal monographs to fa-cilitate registrations and authorisations of herbal medicinal products in the European Union 2004-2012 [ J ]. Journal of Ethnopharmacology ,2014,158:471-486.
  • 4European Medicines Agency. Overview of assessment work- Priority list [ EB/OL]. http ://www, ema, europa, eu/docs/ en_ G B/ document_library / Other/2009 /12/W C500017 72 4. pdf, 2015 -07 -24/2015 -09 -23.
  • 5European Medicines Agency. Procedure on management of proposals submitted by interested parties for community list entries or community herbal monographs[ EB/OL]. http:// www. ema. europa, eu/docs/en_GB/documentlibrary/Reg- ulatory_ and_procedural_guideline/ 2009 /12/ W C500016900. pdf,2009-11-12/2015-09-23.
  • 6邹文俊,瞿礼萍,叶祖光,姬建新,李伯刚.欧盟传统草药专论述评[J].中国中药杂志,2011,36(23):3386-3388. 被引量:9
  • 7European Medicines Agency. Curcuma [ EB/OL ]. http :// www. ema. europa, eu/ema/index, jsp? curl = pages/medi- cines/herbal/medicines/herbal_med 000065. jsp&mid = WC0bO1 ac058001 fal d, 2009-11-12/2015 -09-23.
  • 8European Medicines Agency. Assessment report on Curcu-ma longa L. [ EB/OL ]. http://www, ema. europa, eu/ docs/en_ GB/document_ library/Herbal_-_ HMPC_ assess- ment _ report/2010/02/WC500070700, pdf, 2009-11-12/ 2015-09-23.
  • 9European Medicines Agency. Overview of comments re- ceived on community herbal monograph on Curcuma longa L. [ EB/OL]. http ://www. ema. europa, eu/docs/en_GB/ document_library/Herbal-_Overview of comments re- ceived_during_consultation/2010/02/WC500070704, pdf, 2010-03-11/2015-09-23.
  • 10European Medicines Agency. Community herbal mono- graph on Curcuma Ionga L. [EB/OL]. http://www. ema. europa, eu/docs/en GB/document_library/Herbal_- _Community_herbal monograph/2010/02/WC500070703. pdf,2009-11-12/2015-09-23.

二级参考文献22

  • 1The European Parliament and the Council of the European Union. Directive 2004/24/EC of the European Parliament and the Council of 31 March 2004 amending, as regards traditional herbal medicinal products, Directive 2001/83/EC on the Community code relating to medicinal products for human use[J]. Official Journal of the European Union, 2004, 47(L-136) : 85.
  • 2European Medicines Agency. Procedure for the preparation of community monographs for traditional herbal medicinal products( EMEA/HMPC/182320/2005 ) [ EB/OLI. 2007-01-11 [ 2011-08- 01 ]. http://www, ema. europa, eu/docs/en_GB/document_librar- y/Regulatory_and_procedural_guideline/2009/12/WC500017012. pdf.
  • 3European Medicines Agency. Guideline on the assessment of clinical safety and efficacy in the preparation of community herbal monographs for well-established and of community herbal monographs/ entries to the community list for traditional herbal medicinal products/substances/preparations ( EMEA/HMPC/104613/2005 ) [ EB/OL ]. 2006-09-07 [ 2011-08-01 ]. http://www, ema. euro-pa. eu/docs/en_GB/document library/Scientific_guideline/2009/ 09/WC500003644. pdf.
  • 4European Medicines Agency. Guideline on non-clinical documentation for herbal medicinal products in applications for marketing authorization (bibliographical and mixed applications) and in applications for simplified registration ( EMEA/HMPC/32116/2005 ) [ EB/OL]. 2006-09-07 [ 2011-08-01 ]. http://www, emea. europa. eu/docs/en_GB/document_library/Scientific_guideline/2009/ 09/WC500003576. pdf.
  • 5European Medicines Agency. Public statement on the interpretation of the term "external use" for use in the field of traditional herbal medicinal products ( EMEA/HMPC/31897/2006 ) [ EB/OL ]. 2006-05-12 [ 2011-08-01 ]. http ://www. ema. europa, eu/docs/en GB/doeument _ library/Public _ statement/2009/12/ WC500017165. pdf.
  • 6European Medicines Agency. Action plan for herbal medicines 2010-2011 (EMA/831327/2009) [ EB/OL]. 2010-06-11 [2011- 08-01]. http://www, ema. europa, eu/docs/en_GB/document_library/Other/2010/O6/WC500093179, pdf.
  • 7Williamson E M, Lorene A, Booker A, et al. The rise oftraditional Chinese medicine and its materia medica: A comparison of the frequency and safety of materials and species used in Europe and China [J]. J Ethnopharmacol, 2013, 149(2): 453-462.
  • 8Steirahoff B. The first HMPC community herbal monographs [J]. Phytomedicine, 2006, 13(5): 378-379.
  • 9Committee on Herbal Medicinal Products. Guideline on the assessment of clinical safety and efficacy in the preparation of community herbal monographs for well-established and of community herbal monographs/ entries to the community list for traditional herbal medicinal products/substances/preparations [S/OL]. 2006- 09-07. http ://www.ema.europa.eu/doc s/en_GB/document_ library/Scientific_guideline/2009/O9AVCSOOOO3644.pdf.
  • 10European Medicines Agency. Uptake of the traditional use registration scheme and implementation of the provisions of directive 2004/24EC in EU Member States (revision 3) [S/OL]. 2013-05-08. http://www.ema.europa. eu/ docs/en_GB/ document library /Report/2011/0 5 /W C 500106706.pdf.

共引文献15

同被引文献23

引证文献4

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部